Hannah Wilkins

Hannah Wilkins is a Scientist in Immunopeptidomics and Mass Spectrometry at Moderna, starting in February 2025. Prior to this role, Hannah was a PhD student at The Johns Hopkins University School of Medicine from June 2020 to February 2025, focusing on the molecular mechanisms at the blood-brain barrier affecting HIV antiretroviral drug metabolism and transport, and developing LC-MS/MS methods for proteomic analyses. Additional experience includes a Drug Metabolism and Pharmacokinetic Intern role at Merck, where methods for ligand binding assays were designed, and a research assistant position at the Applied Physical Sciences Department at UNC-Chapel Hill, studying peptide-DNA hybrid molecules. Hannah holds a PhD in Biochemistry, Cellular & Molecular Biology from The Johns Hopkins University and dual undergraduate degrees in Biology and Hispanic Literature and Cultures from the University of North Carolina at Chapel Hill.